T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Adtran
ADTN
$658M
| $551K | ﹤0.01% |
92,865
+652
| +0.7% | +$3.63K |
|
2202
IES Holdings
IESC
$14.9B
| $545K | ﹤0.01% |
2,728
+78
| +3% | +$12.6K |
|
2203
Bumble
BMBL
$359M
| $544K | ﹤0.01% |
85,212
-63,001
| -43% | -$474K |
|
|
CWEN.A
2204
DELISTED
Clearway Energy Class A
CWEN.A
| $543K | ﹤0.01% |
19,070
+803
| +4% | +$20.5K |
|
2205
OneSpaWorld
OSW
$2.73B
| $543K | ﹤0.01% |
32,841
+900
| +3% | +$14.3K |
|
2206
BrightView Holdings
BV
$1.08B
| $539K | ﹤0.01% |
34,211
+5,125
| +18% | +$74.3K |
|
2207
iShares Core S&P Small-Cap ETF
IJR
$113B
| $537K | ﹤0.01% |
4,586
| – | – |
|
2208
Nabors Industries
NBR
$1.35B
| $537K | ﹤0.01% |
8,321
+77
| +0.9% | +$5.94K |
|
|
GOGL
2209
DELISTED
Golden Ocean Group
GOGL
| $533K | ﹤0.01% |
39,773
+1,322
| +3% | +$16.4K |
|
2210
Healthcare Services Group
HCSG
$1.45B
| $532K | ﹤0.01% |
47,580
+5,951
| +14% | +$65.3K |
|
2211
Orthofix Medical
OFIX
$415M
| $530K | ﹤0.01% |
33,918
+669
| +2% | +$10.7K |
|
2212
Willis Lease Finance
WLFC
$1.15B
| $529K | ﹤0.01% |
10,647
-3,105
| -23% | -$102K |
|
2213
Sinclair Inc
SBGI
$1.03B
| $528K | ﹤0.01% |
34,465
+775
| +2% | +$10.8K |
|
2214
Birkenstock
BIRK
$7.54B
| $527K | ﹤0.01% |
10,688
+4,607
| +76% | +$251K |
|
|
TDAY
2215
USA Today Co
TDAY
$1B
| $527K | ﹤0.01% |
93,625
+2,820
| +3% | +$13.7K |
|
2216
iShares Biotechnology ETF
IBB
$9.77B
| $527K | ﹤0.01% |
3,614
| – | – |
|
2217
Manitowoc
MTW
$753M
| $525K | ﹤0.01% |
54,559
+14,462
| +36% | +$151K |
|
2218
Maravai LifeSciences
MRVI
$861M
| $523K | ﹤0.01% |
62,882
+1,019
| +2% | +$8.81K |
|
2219
Limbach Holdings
LMB
$527M
| $521K | ﹤0.01% |
6,867
+58
| +0.9% | +$3.69K |
|
2220
PACS Group
PACS
$7.12B
| $517K | ﹤0.01% |
+12,926
| New | +$470K |
|
2221
NVE Corp
NVEC
$563M
| $514K | ﹤0.01% |
6,424
-2,298
| -26% | -$182K |
|
2222
Personalis
PSNL
$1.54B
| $512K | ﹤0.01% |
95,000
| – | – |
|
|
REFI
2223
Chicago Atlantic Real Estate Finance
REFI
$264M
| $512K | ﹤0.01% |
33,006
+5,201
| +19% | +$81.6K |
|
|
ZEUS
2224
DELISTED
Olympic Steel
ZEUS
| $510K | ﹤0.01% |
13,052
+2,487
| +24% | +$105K |
|
2225
Trip.com Group
TCOM
$28.3B
| $509K | ﹤0.01% |
+8,550
| New | +$396K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.